NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Researchers, clinicians and executives react to Compass Pathways’ second positive Phase 3 psilocybin readout in treatment-resistant depression.
Compass announces promising yet modest results from second Phase 3 psilocybin trial; Missouri hearings on ibogaine and psilocybin bills, New Hampshire psilocybin bill advances
Plus: Helus’s DMT formulation shows promise in treating depression and Compass laying groundwork for COMP360 trigger law in Vermont
9 Lies Therapy Culture Tells About Being Human
Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.
As Climate Grief Deepens, Psychedelic Therapy Enters the Chat
Researchers and therapists are exploring whether psychedelic treatment can help people metabolize planetary loss. [...] Read More... The post As Climate Grief Deepens, Psychedelic Therapy Enters the Chat appeared firs...
What should I look for in a psychedelic training course?
As psychedelic therapeutic practices move towards above-ground legal practice and underground psychedelic use increases, interest in education and training around psychedelics and their therapeutic use is high. So i...
11 Million Reasons We Need Peer Support
A recent national survey investigated how many Americans used psychedelics in 2025, and the… The post 11 Million Reasons We Need Peer Support appeared first on Zendo Project.
Melissa Lavasani & Jay Kopelman: Federal Psychedelic Policy, VA Pathways, and Ibogaine Safety Standards
Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educa...
Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts
We present the psychedelic drug development pipeline in two ‘bullseye chart’ formats, as of Q1 2026.
My FIRST OPINION in STATnews
I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
A new data release from Enveric Biosciences is sharpening the scientific debate at the heart of psychedelic drug development: can therapeutic benefit be separated from hallucination at the receptor level? In results a...
How Do Psychedelics Change One’s Relationship to Boredom?
Oli Genn-Bash argues that boredom may be more damaging than stress in modern overstimulated life because it reflects a lack of meaning and connection, and while psychedelics don’t eliminate boredom, they may reshape o...
Couples Are Turning to Ketamine-Assisted Therapy to Heal Their Relationships
As couples’ therapists, we see the same painful sticking points again and again. Couples arrive at therapy with a familiar experience: “We love each other, but we can’t seem to understand or reach each other anymore. ...
Can Psychedelics Help Us Make Peace with Death?
A new wave of thinkers is reimagining how we prepare for our final passage. [...] Read More... The post Can Psychedelics Help Us Make Peace with Death? appeared first on DoubleBlind Mag.
PSYCH NEWS – 18/02/26
In February 2026, major advances in psychedelic medicine included a rapid 25-minute DMT therapy showing strong results for depression, psilocybin moving closer to regulatory approval, growing evidence that ketamine’s ...
Varying Approaches to Psychedelic Policy Reform in Washington State
Lawmakers in Washington state have been debating two distinct and often conflicting visions for the regulation of psychedelics that reflects national tensions about the future of psychedelic therapies. The post Varyin...